President Trump at an Oval Office event on increasing access for Americans to weight loss drugs. Photo by ANDREW CABALLERO-REYNOLDS/AFP via Getty Images

Americans are going to get a little healthier.

President Donald Trump this week cut deals with the drug-makers Eli Lilly and Novo Nordisk to increase access to obesity drugs in a major benefit to American public health.

The agreements are a win-win-win — good for consumers , good for the companies and good for Trump.

One of the most irrational superstitions of our time is that Big Pharma, which has for decades been routinely delivering near-miraculous therapeutics to extend and improve our lives, is a public enemy.

Its latest breakthrough is a class of so-called GLP-1 drugs that make it easier to lose weight, and to avoid associa

See Full Page